TSPO and Parkinson disease: Conversely, the authors didn’t find any correlation between the binding parameters of [18F]-FE-PE21, which were markedly decreased in the nigrostriatal pathway, and [11C]-PBR28, suggesting that dopaminergic pathology and TSPO binding are independent factors in patients with PD [20].